George Medicines Is A Late Stage Biopharmaceutical Company Dedicated To Developing Innovative Treatments For Cardiometabolic Diseasesincluding Heart Diseasehypertensionand Diabetesas A Spin Out From The George Institute For Global Healthit Leverages Extensive Research To Create Effective Medical Solutionsgeorge Medicines Is Part Of George Healthwhich Focuses On Commercializing Medicines And Technologies Derived From The Institute S Research The Company Specializes In Formulating Existing Best In Class Treatments Into Single Pillmulti Mechanism Productsthis Strategy Aims To Enhance Efficacysafetyand Affordability Compared To Current Alternativesone Of Its Lead Candidatesgmrx2Is A Novel Triple Combination Product For Hypertension Managementcombining Telmisartanamlodipineand Indapamide In A Single Pillgmrx2 Has Successfully Completed Two International Phase Iii Clinical Trials And A New Drug Application Has Been Submitted To The Us Fdageorge Medicines Operates Globallywith A Presence In The Uk And Partnerships That Support Its Innovative Drug Development Approach
